1. Home
  2. BLCO vs KEX Comparison

BLCO vs KEX Comparison

Compare BLCO & KEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLCO
  • KEX
  • Stock Information
  • Founded
  • BLCO 1853
  • KEX 1921
  • Country
  • BLCO Canada
  • KEX United States
  • Employees
  • BLCO N/A
  • KEX N/A
  • Industry
  • BLCO Ophthalmic Goods
  • KEX Marine Transportation
  • Sector
  • BLCO Health Care
  • KEX Consumer Discretionary
  • Exchange
  • BLCO Nasdaq
  • KEX Nasdaq
  • Market Cap
  • BLCO 4.9B
  • KEX 5.4B
  • IPO Year
  • BLCO 2022
  • KEX N/A
  • Fundamental
  • Price
  • BLCO $15.23
  • KEX $84.47
  • Analyst Decision
  • BLCO Hold
  • KEX Strong Buy
  • Analyst Count
  • BLCO 11
  • KEX 2
  • Target Price
  • BLCO $15.80
  • KEX $121.00
  • AVG Volume (30 Days)
  • BLCO 492.5K
  • KEX 939.2K
  • Earning Date
  • BLCO 10-29-2025
  • KEX 10-29-2025
  • Dividend Yield
  • BLCO N/A
  • KEX N/A
  • EPS Growth
  • BLCO N/A
  • KEX 12.00
  • EPS
  • BLCO N/A
  • KEX 5.27
  • Revenue
  • BLCO $4,891,000,000.00
  • KEX $3,274,578,000.00
  • Revenue This Year
  • BLCO $8.27
  • KEX $3.46
  • Revenue Next Year
  • BLCO $5.73
  • KEX $4.38
  • P/E Ratio
  • BLCO N/A
  • KEX $16.02
  • Revenue Growth
  • BLCO 8.81
  • KEX 2.45
  • 52 Week Low
  • BLCO $10.45
  • KEX $83.94
  • 52 Week High
  • BLCO $21.69
  • KEX $132.21
  • Technical
  • Relative Strength Index (RSI)
  • BLCO 59.83
  • KEX 25.68
  • Support Level
  • BLCO $15.00
  • KEX $86.58
  • Resistance Level
  • BLCO $15.50
  • KEX $88.75
  • Average True Range (ATR)
  • BLCO 0.34
  • KEX 2.48
  • MACD
  • BLCO 0.02
  • KEX -0.43
  • Stochastic Oscillator
  • BLCO 72.03
  • KEX 0.74

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About KEX Kirby Corporation

Kirby Corp is a domestic tank barge operator, transporting bulk liquid products throughout three United States coasts. The Company transports petrochemicals, liquid cargoes, inland waterway systems, and dry bulk cargoes. The Company conducts operations in two reportable business segments: The Marine transportation segment which provides marine transportation services, operating tank barges and towing vessels transporting bulk liquid products, and the Distribution and services segment, which provides after-market service, and genuine replacement parts for engines, transmissions, reduction gears, and power generation equipment used in oil and gas and commercial and industrial applications. The company's revenue is generated from the Marine Transportation segment.

Share on Social Networks: